AVAI BIO, INC. (AVAI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Gross Profit Quarterly

-1.1M -700K -350K 0 350K 700K 1.1M Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q1 '20: 6K Q1 '20: 6K Q2 '20: 0 Q3 '20: 0 Q4 '20: -262.3K Q1 '21: 84.6K Q1 '21: 84.6K Q2 '21: 87.4K Q3 '21: 346.2K Q1 '22: 542.9K Q2 '22: -93.4K Q3 '22: 292K Q4 '22: -952.2K Q1 '23: 24.5K Q2 '23: 6.6K Q3 '23: -71.5K Q4 '23: 1 Q2 '19 Q1 '20 Q4 '20 Q2 '21 Q2 '22 Q1 '23 Q4 '23

Operating Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q2 '22: 166.3K Q3 '22: 349.3K Q4 '22: 7.2K Q1 '23: 29.8K Q2 '23: 83.8K Q3 '23: 110.5K Q4 '23: -572.9K Q1 '24: 411.5K Q2 '24: 399.6K Q3 '24: 1M Q4 '24: -4M Q1 '25: -528.8K Q2 '25: 623K Q3 '25: 452.3K Q4 '25: -1.7M Q1 '26: 487.6K Q2 '26: -453K Q3 '26: -553.7K Q4 '26: -255.2K Q1 '27: -552K Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

Net Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q2 '22: -166.3K Q3 '22: -349.3K Q4 '22: -7.2K Q1 '23: -29.8K Q2 '23: -83.8K Q3 '23: -110.5K Q4 '23: -572.9K Q1 '24: -411.5K Q2 '24: -399.6K Q3 '24: -1M Q4 '24: -4M Q1 '25: -528.8K Q2 '25: -625K Q3 '25: -452.3K Q4 '25: 464.1K Q1 '26: 487.6K Q2 '26: -453K Q3 '26: -553.7K Q4 '26: -255.2K Q1 '27: -552K Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

Cost of Revenue Quarterly

0 200K 400K 600K Q2 '20: 0 Q3 '20: 0 Q4 '20: 461.1K Q1 '21: 214.6K Q1 '21: 214.6K Q2 '21: 267.2K Q3 '21: 501K Q4 '21: 247.9K Q1 '22: 215.1K Q2 '22: 152.2K Q3 '22: 331.3K Q4 '22: 11.9K Q1 '23: 102.9K Q2 '23: 0 Q3 '23: 213.9K Q4 '23: 0 Q1 '25: 5.5K Q2 '25: 5.5K Q3 '25: 0 Q4 '25: 3.8K Q3 '20 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '25 Q4 '25

Operating Cash Flow Quarterly

-900K -600K -300K 0 300K 600K 900K Q1 '22: 56.9K Q2 '22: 177.7K Q3 '22: 395.3K Q1 '23: -95.6K Q2 '23: 82K Q3 '23: 32.6K Q4 '23: -73.5K Q1 '24: -59.7K Q2 '24: -420.4K Q3 '24: -705.7K Q4 '24: -136.5K Q1 '25: -12.7K Q2 '25: -826.1K Q3 '25: -134.4K Q4 '25: -187.5K Q1 '26: -240.3K Q2 '26: -371.5K Q3 '26: -347.1K Q4 '26: -50.8K Q1 '27: -414.3K Q2 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

Free Cash Flow Quarterly

-9K -6K -3K 0 3K 6K 9K Q3 '19: -8.5K Q3 '19

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q3 '20: 5M Q1 '21: 26.3M Q2 '21: 26.3M Q3 '21: 26.3M Q1 '22: 26.3M Q2 '22: 26.3M Q3 '22: 26.3M Q1 '23: 26.3M Q2 '23: 32.2M Q3 '23: 32.2M Q1 '24: 57.6M Q2 '24: 74.3M Q3 '24: 74.8M Q1 '25: 115.8M Q2 '25: 123.6M Q3 '25: 137M Q1 '26: 137.5M Q2 '26: 137.6M Q3 '26: 138M Q1 '27: 153.9M Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26 Q1 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.02 -0.01 -0.01 0.00 0.01 0.01 0.02 Q2 '22: 0.00 Q3 '22: 0.00 Q4 '22: 0.00 Q1 '23: 0.00 Q2 '23: 0.00 Q3 '23: 0.00 Q4 '23: 0.00 Q1 '24: 0.00 Q2 '24: -0.01 Q3 '24: -0.02 Q4 '24: -0.02 Q1 '25: -0.02 Q2 '25: -0.02 Q3 '25: -0.01 Q4 '25: -0.01 Q1 '26: -0.01 Q2 '26: 0.00 Q3 '26: 0.00 Q4 '26: 0.00 Q1 '27: 0.00 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.